With the aim to study the effective anti-inflammatory properties of these new psoralen derivatives, we decided to further characterize the TMA derivatives for their potential activities on the expression of IL-8 gene, known to be involved in the lung inflammatory process in CF. This evidence concerns the gene CXCL8 and cystic fibrosis.